gabapentin
Generic: gabapentin
Labeler: aphena pharma solutions - tennessee, llcDrug Facts
Product Profile
Brand Name
gabapentin
Generic Name
gabapentin
Labeler
aphena pharma solutions - tennessee, llc
Dosage Form
CAPSULE
Routes
Active Ingredients
gabapentin 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71610-185
Product ID
71610-185_e1f89ae6-021d-4fcd-ad58-27f2be19fd6e
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA090705
Listing Expiration
2026-12-31
Marketing Start
2018-09-13
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
71610185
Hyphenated Format
71610-185
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gabapentin (source: ndc)
Generic Name
gabapentin (source: ndc)
Application Number
ANDA090705 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
Packaging
- 30 CAPSULE in 1 BOTTLE (71610-185-30)
- 60 CAPSULE in 1 BOTTLE (71610-185-53)
- 90 CAPSULE in 1 BOTTLE (71610-185-60)
- 120 CAPSULE in 1 BOTTLE (71610-185-70)
- 180 CAPSULE in 1 BOTTLE (71610-185-80)
- 270 CAPSULE in 1 BOTTLE (71610-185-92)
- 360 CAPSULE in 1 BOTTLE (71610-185-94)
Packages (7)
71610-185-30
30 CAPSULE in 1 BOTTLE (71610-185-30)
71610-185-53
60 CAPSULE in 1 BOTTLE (71610-185-53)
71610-185-60
90 CAPSULE in 1 BOTTLE (71610-185-60)
71610-185-70
120 CAPSULE in 1 BOTTLE (71610-185-70)
71610-185-80
180 CAPSULE in 1 BOTTLE (71610-185-80)
71610-185-92
270 CAPSULE in 1 BOTTLE (71610-185-92)
71610-185-94
360 CAPSULE in 1 BOTTLE (71610-185-94)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e1f89ae6-021d-4fcd-ad58-27f2be19fd6e", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310431"], "spl_set_id": ["a900bafb-8f49-4a01-ba7f-4fb228ec0253"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (71610-185-30)", "package_ndc": "71610-185-30", "marketing_start_date": "20181102"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (71610-185-53)", "package_ndc": "71610-185-53", "marketing_start_date": "20181102"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (71610-185-60)", "package_ndc": "71610-185-60", "marketing_start_date": "20181112"}, {"sample": false, "description": "120 CAPSULE in 1 BOTTLE (71610-185-70)", "package_ndc": "71610-185-70", "marketing_start_date": "20181102"}, {"sample": false, "description": "180 CAPSULE in 1 BOTTLE (71610-185-80)", "package_ndc": "71610-185-80", "marketing_start_date": "20181112"}, {"sample": false, "description": "270 CAPSULE in 1 BOTTLE (71610-185-92)", "package_ndc": "71610-185-92", "marketing_start_date": "20181112"}, {"sample": false, "description": "360 CAPSULE in 1 BOTTLE (71610-185-94)", "package_ndc": "71610-185-94", "marketing_start_date": "20181112"}], "brand_name": "GABAPENTIN", "product_id": "71610-185_e1f89ae6-021d-4fcd-ad58-27f2be19fd6e", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "71610-185", "generic_name": "GABAPENTIN", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GABAPENTIN", "active_ingredients": [{"name": "GABAPENTIN", "strength": "300 mg/1"}], "application_number": "ANDA090705", "marketing_category": "ANDA", "marketing_start_date": "20180913", "listing_expiration_date": "20261231"}